Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Tanvira Afroze Sultana"'
Autor:
Mohammad Sorowar Hossain, Enayetur Raheem, Tanvira Afroze Sultana, Shameema Ferdous, Nusrat Nahar, Sazia Islam, Mohammad Arifuzzaman, Mohammad Abdur Razzaque, Rabiul Alam, Sonia Aziz, Hazera Khatun, Abdur Rahim, Manzur Morshed
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 12, Iss 1, Pp 1-9 (2017)
Abstract Thalassemias are emerging as a global public health concern. Due to remarkable success in the reduction of childhood mortality by controlling infectious diseases in developing countries, thalassemias are likely to be a major public health co
Externí odkaz:
https://doaj.org/article/a8a569c5a03c408daa6c98a4c2f50db3
Autor:
Nahid Sultana, Fayeza Karim, Tunerjina Akhter, Tanvira Afroze Sultana, Qazi Shamima Akter, Afruza Khanam
Publikováno v:
Bangladesh Medical Journal. 46:80-84
Diabetes mellitus (DM) is the leading cause of many chronic diseases. Anemias in men with diabetes mellitus greatly contribute to the pathogenesis and progression of cardiovascular disease and aggravate diabetic nephropathy and retinopathy. The prese
Autor:
Subhagata Choudhury, Tanvira Afroze Sultana, MA Muttalib, Nadia Zebin Khan, Gazi Sharmin Sultana, Zannat e Khuda, Tashmim Farhana Dipta
Publikováno v:
BIRDEM Medical Journal. 8:114-117
Background: HbA1c is considered as “gold standard” to evaluate glycemic control in patients with diabetes. Hemoglobin variants are mutant forms of hemoglobin that can occur by genetic changes in specific amino acid that can affect the accuracy of
Autor:
TA Nasir, Sohrab Alam, Tanvira Afroze Sultana, Rubyyat Hasan, Gazi Sharmin Sultana, Mizanur Rahman, Rumana Rahim
Publikováno v:
Pulse. 8:51-61
Molecular diagnosis is rapidly becoming an inseparable part of disease diagnosis. This cutting edge technology can be used to diagnose both infectious and malignant diseases as well as to help in determining drug dosage, tissue types for organ transp
Autor:
Akm Shaheen Ahmed, Hasna Fahmima Haque, Pratik Dewan, Tanvira Afroze Sultana, Khwaja Nazim Uddin, Muhammad Abdur Rahim
Publikováno v:
Journal of Medicine. 16:124-127
Relapsing polychondritis (RP) is a rare systemic inflammatory disorder having predilection for cartilaginous structures specially ears, nose, joints and respiratory tract. Myelodysplastic syndrome (MDS) is an established association. Here we describe
Publikováno v:
Cancer epidemiology. 51
Introduction The adolescent and young adult (AYA) age group (15–39 years) bears distinct characteristics in terms of cancer biology, long-term health and treatment-related complications and psychosocial aspects. The overall scenario of cancer inclu
Autor:
Parvin Akter Khanam, Subhagata Choudhury, Tanvira Afroze Sultana, M Sirazul Islam, M Aminul Islam
Publikováno v:
Journal of the Asiatic Society of Bangladesh, Science. 38:189-198
Bone marrow morphological examination was performed on 835 patients either admitted in the inpatient departments of BIRDEM General Hospital or examined on outpatient basis. 760 of them were adults and 75 of them were children. 74 of the patients were
Autor:
Kinro Ito, Hideo Tanaka, Takuo Ito, Li-Gen Liu, Taiichi Kyo, Tanvira Afroze Sultana, Akiro Kimura
Publikováno v:
Acta Haematologica. 113:113-123
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an interferon (IFN)-induced molecule with apoptotic activity. We examined gene mutations in the death domains of TRAIL receptor 1 (TRAIL-R1) and TRAIL receptor 2 (TRAIL-R2), and in th
Autor:
Akiro Kimura, Tanvira Afroze Sultana
Publikováno v:
Leukemia & Lymphoma. 45:1995-2000
We studied surface expression of granulocyte colony-stimulating factor receptor (G-CSFR) on CD34 + + progenitor cells of myelodysplastic patients. Late stages of disease showed a higher proportion of high or low G-CSFR expression than early stages. M
Autor:
Hideo Tanaka, Fumio Imanaka, Kinro Ito, Tanvira Afroze Sultana, Taiichi Kyo, Yasukazu Ohmoto, Akiro Kimura, Takuo Ito
Publikováno v:
European Journal of Haematology. 73:191-205
In order to investigate the mechanism of interferon-alpha (IFNalpha) action in the treatment of chronic myelogenous leukemia (CML), we examined surface expressions of both type I interferon receptor 1 (IFNAR1) and 2 (IFNAR2) subunits on CD34-positive